Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

API Manufacturing: SOP for Review of Product Labels and Packaging Materials – V 2.0

Posted on By

API Manufacturing: SOP for Review of Product Labels and Packaging Materials – V 2.0

Standard Operating Procedure for Review of Product Labels and Packaging Materials in API Manufacturing

Department API Manufacturing
SOP No. SOP/API/190/2025
Supersedes SOP/API/190/2022
Page No. Page 1 of 15
Issue Date 14/04/2025
Effective Date 16/04/2025
Review Date 14/04/2026

1. Purpose

To define a standard procedure for the Quality Assurance (QA) review, approval, and control of product labels, printed packaging materials, and associated information to ensure that all labels and packaging meet regulatory, customer, and internal quality requirements in API manufacturing.

2. Scope

This SOP applies to all printed

labels, cartons, tags, and other packaging materials used for labeling, packing, and shipping of Active Pharmaceutical Ingredients (APIs), intermediates, and reference standards. It includes both in-house and externally printed materials.

3. Responsibilities

  • Packaging or Stores Department: Initiates label requests, handles procurement, and submits samples for approval.
  • QA Department: Reviews label and artwork content, cross-verifies regulatory data, and maintains label control records.
  • QC Department: Verifies printed data during usage and sampling.
See also  API Manufacturing: SOP for Monitoring of Recovered Solvent Odor and Clarity - V 2.0

4. Accountability

The Head of Quality Assurance is accountable for ensuring that no label or packaging component is used unless approved, validated, and verified for accuracy, GMP compliance, and traceability.

5. Procedure

5.1 Initiation of Label Review

  1. The concerned department (e.g., Production, Packaging, Regulatory Affairs) shall submit a Label Approval Request Form (Annexure-1) along with the draft label/artwork or updated design to QA.
  2. Label revisions must be supported by Change Control documentation if they affect regulatory content or format.

5.2 Elements of Label/Packaging Review

  1. QA shall review labels and printed packaging materials for:
    • Correct Product Name and Code
    • Batch Number placeholder (variable field)
    • Manufacturing Date and Retest/Expiry Date
    • Net weight and packaging size
    • Storage conditions (as applicable)
    • Regulatory declarations (if required)
    • Correct artwork, fonts, color coding, barcodes
    • Revision status and document number
  2. Cross-checking shall be done against:
    • Product Specification File
    • Customer/market requirements
    • Previous version for changes
    • Pharmacopoeial or regulatory statements
  3. Discrepancies, errors, or deviations shall be documented in the Label Review Comment Form (Annexure-2).

5.3 Approval and Version Control

  1. Upon satisfactory review, QA shall:
    • Sign the Label Approval Sheet (Annexure-3)
    • Assign an internal approval number or control ID
    • Record details in the Label Control Register (Annexure-4)
  2. Only approved versions shall be printed and used. All obsolete versions shall be marked “OBSOLETE” and archived.
See also  API Manufacturing: SOP for Visual Inspection of Semi-Solid Intermediates - V 2.0

5.4 Printing and Verification

  1. Label printing shall be done only against an approved and controlled master copy.
  2. During printing and issuance:
    • QA shall verify initial batch-specific overprints (Batch No., Mfg. Date, etc.)
    • Any discrepancies must be reported, and labels segregated
  3. Print samples shall be filed with the packaging batch record.

5.5 Usage and Reconciliation

  1. QA shall reconcile label issuance and usage for each batch using the Label Usage Log (Annexure-5).
  2. Any excess or damaged labels must be destroyed in the presence of QA and recorded accordingly.

5.6 Storage and Security

  1. All approved labels and printed packaging materials shall be stored in a restricted access area under lock and key controlled by QA or an authorized person.
  2. Obsolete or rejected labels must be removed from access immediately and documented for destruction.

6. Abbreviations

  • QA: Quality Assurance
  • QC: Quality Control
  • SOP: Standard Operating Procedure
  • API: Active Pharmaceutical Ingredient
  • ID: Identification

7. Documents

  1. Label Approval Request Form (Annexure-1)
  2. Label Review Comment Form (Annexure-2)
  3. Label Approval Sheet (Annexure-3)
  4. Label Control Register (Annexure-4)
  5. Label Usage Log (Annexure-5)
See also  API Manufacturing: SOP for Distillation and Purification of Recovered Solvents - V 2.0

8. References

  • ICH Q7 – Section 9: Packaging and Identification
  • 21 CFR Part 211.122 – Labeling and Packaging Control
  • EU GMP Guide Part II – Section 9
  • WHO GMP for APIs – TRS 957

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Label Approval Request Form

Product Code Requested By Department Date
API-X API01 Rajesh Kumar Production 12/04/2025

Annexure-2: Label Review Comment Form

Label ID Observation Action Suggested QA Reviewer
LBL/API/001 Incorrect expiry format Use dd/mm/yyyy Sunita Reddy

Annexure-3: Label Approval Sheet

Label ID Version Approval Date QA Sign
LBL/API/001 1.0 14/04/2025 QA Head

Annexure-4: Label Control Register

Label ID Product Version Status Remarks
LBL/API/001 API-X 1.0 Active —

Annexure-5: Label Usage Log

Date Batch No. Label ID Qty Issued Qty Used Qty Destroyed
13/04/2025 API01/2504/001 LBL/API/001 500 480 20

Revision History:

Revision Date Revision No. Details Reason Approved By
01/01/2022 1.0 Initial release New SOP QA Head
14/04/2025 2.0 Updated format and reconciliation process Regulatory alignment QA Head
API Manufacturing V 2.0 Tags:API batch record, API BMR, API calibration, API centrifuge, API cleaning, API crystallization, API deviation, API documentation, API drying, API equipment cleaning, API filtration, API GMP compliance, API granulation, API hold time, API impurities, API line clearance, API manufacturing, API process, API quality control, API reactor, API sampling, API solvent handling, API validation, API waste disposal, API yield

Post navigation

Previous Post: Gel Manufacturing: SOP for Conducting Supplier Audits for Raw Materials – V 2.0
Next Post: Biosimilars: SOP for Disposal of Culture Waste – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version